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Abstract
Background: ED overcrowding represents a significant public health problem in developed countries. Frequent
users of the emergency departments (FUEDs; reporting 5 or more ED visits in the past year) are often affected by
medical, psychological, social, and substance use problems and account for a disproportionately high number of ED
visits. Past research indicates that case management (CM) interventions are a promising way to reduce ED
overcrowding and improve FUEDs’ quality of life. There is, however, very limited knowledge about how to
disseminate and implement this intervention on a large scale to diverse clinical settings, including community
hospitals and non-academic centers. This paper describes the protocol of a research project aiming to implement a
CM intervention tailored to FUEDs in the public hospitals with ED in the French-speaking region of Switzerland and
evaluate both the implementation process and effectiveness of the CM intervention.
Methods: This research project uses a hybrid study design assessing both implementation and clinical outcomes.
The implementation part of the study uses mixed methods a) to describe quantitatively and qualitatively factors
that influence the implementation process, and b) to examine implementation effectiveness. The clinical part of the
study uses a within-subject design (pre-post intervention) to evaluate participants’ trajectories on clinical variables
(e.g., quality of life, ED use) after receiving the CM intervention. We designed the study based on two
implementation science frameworks. The Generic Implementation Framework guided the overall research protocol
design, whereas the RE-AIM (reach, efficacy, adoption, implementation and maintenance) framework guided the
implementation and effectiveness evaluations.
Discussion: This research project will contribute to implementation science by providing key insights into the
processes of implementing CM into broader practice. This research project is also likely to have both clinical and
public health implications.
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Background
ED overcrowding is a common public-health concern in
developed countries impacting both patients and health
system outcomes [1]. For instance, there are over 1.4
million annual ED visits in Switzerland (8.5 million in-
habitants) with 84% of EDs reporting overcrowding [2].
Frequent users of the emergency departments (i.e.,
FUEDs; reporting 5 or more ED visits in the past year)
[3] are in need of targeted attention from clinicians,
public health advisors and researchers. FUEDs dispro-
portionately access ED services, and contribute to ED
overcrowding (i.e., FUEDs account for 3 to 8% of all pa-
tients and 12 to 28% of all ED visits) [4–6]. Driving this
high use of health care services is the fact that FUEDs
are often affected by multiple chronic medical diseases
(e.g., heart disease, cancer) [7–9], as well as psychiatric,
substance use and social problems (e.g., unemployment
or social isolation) [4, 10–12]. In response, important re-
search efforts have been dedicated to identify, develop
and test interventions tailored to this population, such
as case management (CM) intervention. Past research
has found CM intervention as a promising way to re-
duce ED overcrowding and improve FUEDs’ quality of
life [3, 12–16]. However, there is limited knowledge
about how to disseminate and implement such an inter-
vention on a large scale to diverse clinical settings, in-
cluding community hospitals and non-academic centers.
Implementation science provides a framework for inte-
grating evidence-based interventions, such as the CM
intervention, in real-world settings while evaluating their
feasibility, acceptability and effectiveness over the imple-
mentation process. In this article, we describe the proto-
col of a study funded by the Swiss National Science
Foundation (FNS 407440_167341) that aims to imple-
ment a CM intervention for FUEDs in several hospitals
in the French-speaking region of Switzerland.
The evidence-based practice being implemented
In line with FUEDs’ specific needs, the CM interven-
tion aims at redirecting and reorienting FUEDs to a
range of services within the hospital and
community-based settings to improve the quality of
care for these patients and reduce the ED overcrowding
that negatively impacts all ED patients [12]. The CM
intervention targets several mechanisms through which
the CM intervention is expected to decrease FUEDs
ED visits and related costs and to increase their quality
of life. In addition to cares coordination, these mecha-
nisms include health care empowerment (i.e., being en-
gaged, informed, collaborative and committed to one’s
health care) [17], perceived self-efficacy (i.e., the belief
in one’s ability to perform a task) [18], and health liter-
acy (i.e., skills to meet the complex demands related to
health) [19].
Building on previous findings related to CM effective-
ness [12], our research team developed and tested a
CM intervention tailored to FUEDs in Lausanne Uni-
versity Hospital [3, 20]. Based on FUEDs needs and
characteristics [21, 22] this intervention targets several
specific components. First, the case managers provide
counseling and education on health care utilization,
substance abuse and the social determinants of health
related to FUEDs, using skills such as motivational
interviewing and cross-cultural competences [23, 24].
Additionally, the case managers enable access to con-
crete services, such as social services (i.e., providing
support on income assistance, stable housing, improved
health insurance coverage), and refer FUEDs to psychi-
atric, substance abuse treatment, and/or medical ser-
vices (e.g., GP or medical specialist) on a case-by-case
basis. Another key element of the CM intervention is
to connect all health care or social service providers
within the hospital and in the community, promoting
continuity of care and improving the FUEDs’ ability to
navigate the complex health care system. Along with
this key dimension of the CM intervention, case man-
agers send on a case-by-case basis letters summing up
their intervention to FUEDs’ general practitioners or
other involved health-care providers.
Case management intervention effectiveness
Previous research among FUEDs has established CM
intervention effectiveness in improving housing and en-
vironmental quality of life and reducing homelessness
[12, 13]. There is however, mixed evidence of CM inter-
vention effectiveness in reducing ED use. On one hand,
systematic reviews conducted in 2011 [12] and 2016 [14]
on interventions including CM, care navigation, patient
education and disease specific management programs,
found that CM intervention only consistently reduced
frequent ED use. On the other hand, results yielded in
the few randomized clinical trials conducted to date are
mixed [3, 15, 25, 26]. For instance, a recent randomized
clinical trial conducted by our research team tested CM
intervention efficacy [3]. FUEDs were randomized to the
CM intervention or control groups. After 12 months,
participants in the intervention group made 2.71 (+/−
0.23) ED visits versus 3.35 (+/− 0.32) visits in the control
group (ratio 0.81, 95% CI 0.63–1.02), corresponding to a
19% absolute reduction in ED use. Of important note
however, findings indicated that CM intervention effect
on the number of ED visits was not significant. There-
fore, although most findings support CM intervention
effectiveness in reducing ED use and improving FUED’s
quality of life, research further evaluating these questions
is needed. Accordingly, we selected a hybrid design for
this current study, examining both implementation and
clinical outcomes [27].
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The guiding implementation science framework
Numerous conceptual frameworks exist to guide the de-
sign of research aiming to implement evidence-based
practices in real-world settings. In this study, we used
the Generic Implementation Framework [28] to guide
the overall research protocol design and the RE-AIM
(reach, efficacy, adoption, implementation and mainten-
ance) [29] framework to guide the implementation out-
comes evaluation.
The generic implementation framework (GIF)
The GIF was developed based on a systematic review of
the literature on conceptual implementation frameworks
and aimed to provide guidance on the basic components
required in implementation [28]. According to the GIF,
implementation is a non-linear, iterative process, but
may be divided into several stages (i.e., development, ex-
ploration, preparation, operation and sustainability). At
each stage, specific factors strategies and evaluations in-
fluence the implementation process. Specific factors (i.e.,
influencing factors) include barriers and facilitators in-
fluencing the implementation process, such as
health-care providers’ attitudes toward the intervention
being implemented or organizational readiness to
change [30]. Strategies refer to implementation interven-
tions (e.g., clinical staff training) to assist the implemen-
tation process, whereas evaluations occur to assess the
implementation process and outcomes along with the
evaluation of the evidence-based intervention (i.e., the
CM intervention) outcomes. Influencing factors, strat-
egies and evaluations depend on the evidence-based
intervention being implemented and the context in
which it is being implemented. They also vary across set-
tings and throughout stages of the implementation
process. Finally, according to the GIF, influencing factors
exist at multiple levels (e.g., individual or organizational).
Therefore, strategies and evaluations should target nu-
merous levels. We chose the GIF to develop the current
implementation protocol to ensure covering the core
implementation concepts. Each core component of the
GIF was tailored to the current research project, in par-
ticular to the CM intervention being implemented and
to the settings in which it is being implemented.
The RE-AIM framework
In addition to the GIF, we used the RE-AIM framework
to guide the implementation and effectiveness evalua-
tions [29]. According to the RE-AIM framework, imple-
mentation effectiveness depends on five factors: reach,
effectiveness, adoption, implementation and mainten-
ance. Reach refers to the participation rate and represen-
tativeness of the population targeted by the intervention
(i.e., number of patients receiving the intervention di-
vided by the total number of targeted patients), whereas
effectiveness refers to the impact of the intervention (at
the patient-level). Adoption relates to the proportion of
targeted settings adopting the intervention being imple-
mented. Implementation refers to the fidelity with which
the intervention is being delivered in the real-world set-
ting (as compared with the evidence-based intervention
as it was originally designed). Finally, maintenance refers
to the extent to which an evidence-based practice is in-
tegrated and sustained in real-world settings over time.
Accordingly, the proposed evaluation embedded in the
current study protocol targets these five factors.
Aims of the study
To the best of the authors’ knowledge, no previous study
has focused on the implementation of a CM intervention
for FUEDs in Switzerland. French-speaking Switzerland
includes 7 cantons and covers 23% of the extension of
the country (with 2 million persons in 2015). ED overuse
is of practical concern to public health advisors and cli-
nicians. Research focusing on both implementation and
clinical outcomes may provide key insights into the
mechanisms and processes for disseminating and imple-
menting a CM intervention for FUEDs into broader
practice in the real-world settings. This study aims at 1)
implementing a CM intervention for FUEDs in public
hospitals with EDs in the French-speaking region of
Switzerland, 2) studying the process of implementation
of the intervention and, 3) studying CM intervention’s
effectiveness among FUEDs. Regarding the intervention
effectiveness assessment, we expect that FUEDs will
evince improvements in clinical outcomes (e.g., higher
scores in quality of life) and decreases in ED visits after
receiving the CM intervention.
Methods and design
Design
This research project features a Type 2-hybrid study de-
sign focusing on both implementation and clinical out-
comes [27]. The implementation part of the study uses
mixed methods a) to describe both qualitatively and
quantitatively factors that may influence implementation
process and b) to assess implementation outcomes. The
clinical part of the study uses a within-subject design
(pre-post intervention) to evaluate participants’ trajec-
tories after receiving the CM intervention.
Setting
All community and academic public hospitals with an
adult ED opened 24 h/ 7 days per week throughout the
French-speaking region of Switzerland interested in
implementing the CM intervention are eligible. There
are no exclusion criteria.
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Participants
Patients visiting the ED implementing the CM interven-
tion are eligible if they are ≥18 years, able to communi-
cate in a language that is spoken by the local team or a
professional interpreter and have ≥5 ED visits in the past
12 months recorded. Exclusion criteria include present-
ing less than 2 vulnerability dimensions (i.e., social, som-
atic, mental, risk behaviors) besides frequent ED use,
being unable to give informed consent, planning to stay
in Switzerland less than 18 months, not expected to sur-
vive at least 18 months, awaiting for incarceration or be-
ing currently incarcerated, having a family member
already enrolled in the study.
Given that this research study aims to disseminate
and implement a CM intervention, we are neither
aware of the number of hospitals that will eventually
participate, nor of the number of participants who
will be enrolled in each hospital.
The CM intervention
The CM intervention, as developed by our research
team, typically includes the following steps. First,
health-care providers and/or administrative staff de-
tect FUEDs in the ED through an electronic alert in
patients’ files. They then notify the case manager
that a FUED is in the ED. Next, if the FUED visiting
the ED agrees to do so, the case manager makes a
first evaluation of the FUED’s situation in the ED,
aiming to identify his main problems, the involved
health-care network and the priorities that need to
be addressed. After this first contact and if the
FUED agrees ambulatory care, the case manager
writes an intervention report and sets an appoint-
ment with the patient. Notably, case managers send
on a case-by-case basis letters summing up their
intervention to FUEDs’ general practitioner or other
involved physicians. Ambulatory care consists of set-
ting a number of appointments with the case man-
ager on a case-by-case basis (in the ED, in the
community or health-care network, or at the pa-
tient’s home depending on situation and needs).
Concretely, the case manager, together with the pa-
tient, identifies objectives based on the patient’s spe-
cific needs, which will define the total number of
appointments needed. Ambulatory care aims at
reaching these objectives through appointments with
the involved health-care network and referral to spe-
cialized services fitting the patient’s needs. Staff in-
volved in this step include the case manager,
specialized workers from the health-care network,
and sometimes, the patient’s relatives. Whenever
possible, the patient is asked to be active in the de-
cisions taken to address his social and medical needs
(patient empowerment). The intervention concludes
when the patient is integrated into a coordinated
and functional health-care network.
Study procedure, implementation strategies and ethics
The whole project should be completed in 3.5 years over
five phases (see Fig. 1). We present below the study pro-
cedure over the five phases. Table 1 presents a summary
of the implementation strategies by phase. We will use
hereafter the term I-CaM research team to refer to staff
working on the research project in the home institution,
including 2 research assistants (bachelor-level students
in Medicine or Social Sciences), a research nurse (nurse,
MPH), a scientific collaborator (Ph.D), and the research
project leader (Associate Prof, MD, MSc).
The development and exploration phases
The I-CaM research team will develop a CM Toolkit,
the team member selection-support materials and the
informational announcement to be disseminated to eli-
gible hospitals. The I-CaM research team will also de-
velop and send by email a survey aiming to gauge
interest and needs regarding the CM intervention to all
eligible hospitals (to head physicians of EDs). The survey
will include around 20 closed and opened-ended items
addressing awareness, perceptions and knowledge of the
FUED problematic as well as specific needs and interest
regarding the CM. For instance participants will be
asked to indicate how often they faced FUEDs over the
past 2 years using a Likert scale ranging from 0 = never
to 5 = every day, or to describe the main FUED-related
difficulties they encounter. Results will be analyzed using
both descriptive statistics and qualitative content ana-
lysis. Based on the survey results, the I-CaM research
team will reach out to the interest hospitals’ key staff to
provide more information about the CM intervention
and the study procedures. After the meeting, key hos-
pital staff being still interested in the CM intervention
will participate in a one-day workshop at the home insti-
tution, during which they will receive basic training on
the CM intervention, motivational interviewing [24],
cross-cultural competencies [23] and on the study pro-
cedures, complete a questionnaire and participate in a
semi-structured interview. After the workshop, all sites
deciding to adopt the CM intervention will be eligible to
participate in the study. Finally, hospitals not interested
in participating in the study will be proposed participate
in a semi-structured interview aiming to evaluate bar-
riers to CM intervention implementation (face-to-face
or by phone, depending upon possibilities).
The preparation phase
Sites included in the study will prepare for implementa-
tion of the CM intervention using the CM toolkit they
received at the one-day workshop; with I-CaM research
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team support, sites will first identify CM intervention
team members, including strategic and operational
champions and case managers. The champions will a)
promote the implementation project within the hospital,
b) support its implementation and application and, c)
supervise case managers who will be in charge of the
CM intervention administration. Next, available re-
sources will be established at each site and data collec-
tion systems will be finalized to gather data on
implementation and clinical outcomes. The I-CaM re-
search team will also conduct clinical and research train-
ings (i.e., on the informed consent process and data
collection required for the research) to case managers.
Finally, at the end of the preparation phase, champions
and clinicians involved in the project on-site will
complete a questionnaire.
The operation phase
The CM intervention will be implemented at all sites in-
cluded in the study. First, case managers will conduct a
screening process to identify eligible participants. At
each site, patients fulfilling the inclusion criteria will be
contacted by the case managers. The number of partici-
pants included will depend upon each site resources. We
expect that each site will include at least 2 participants
per week on average. The maximum number of inclu-
sions per week per site will be discussed with the re-
search nurse (from I-CaM staff ) in charge of the clinical
training and supervision in order to avoid inducing work
overload. If possible (depending upon resources on each
site), eligible patients having been treated in the ED in
the 10 days prior the recruitment window will be con-
tacted by phone and proposed to come back to the ED
to participate in the study. Remaining FUEDs (i.e., the
FUEDs not invited to participate in the study) will re-
ceive usual care.
When first meeting the participant, the case managers
will present the study and examine the exclusion criter-
ion. If the patient does not have any exclusion criteria
and is interested in participating, the case managers will
conduct the informed consent process. After providing
written consent, participants will receive the CM inter-
vention. After each inclusion on site, the case managers
will up-date the I-CaM research team in charge of the
clinical assessment (i.e., baseline and follow-up assess-
ments of the health-related variables to describe partici-
pants’ trajectories). The I-CaM research team will
contact participants and conduct the baseline assess-
ment within 10 days following the inclusion. Participants
will then complete follow-up assessments at 3, 6 and 12
months post-baseline. All assessment interviews will be
conducted by phone by bachelor-level students (i.e., of
medical or social sciences) who will be trained and
weekly supervised. For all patients, incentives (i.e., gift
cards of 10, 20 and 20 CHF for the 3, 6 and 12-month
follow-ups, respectively) and reminders will be used to
compensate participation and obtain good retention
rates. Other clinical variables (see measures section) will
be directly extracted from medical records on-site by the
I-CaM research team. Each site implementing the CM
Table 1 Description of the Implementation Program Components by Phase
Implementation program
components
Description Implementation
phase
ED staff involvement
Needs and interest assessment I-CaM team sends a survey to all eligible hospitals to assess health-
providers needs and interests regarding the CM intervention.
Exploration 10min
Hospital orientation I-CaM team meets with key ED staff to provide more information about
the CM intervention and the study procedures.
Exploration 2 h
Workshop Interested key ED staff participate in a one-day workshop aiming to pro-
vide basic training on the CM intervention and assist in their decision of
whether to adopt the CM intervention
Exploration 1 day
CM toolkit The CM toolkit includes a detailed description of the CM intervention
components, a validated framework of vulnerability among FUEDs to
use as a screening tool and a booklet with practical information to use
as models for the implementing sites.
Preparation,
operation and
sustainability
Continued use
Team member selection
support
Provides a description of key team member characteristics to support
team member selection at implementing sites
Preparation Continued use
Site visits & training I-CaM team meets with key staff in implementing sites to provide
support to establish available resources on-site, to tailor the CM inter-
vention to local realities and to provide training and coaching regarding
the CM intervention to the full CM team
Preparation 2 visits of 2 h
Coaching, technical assistance
& feedback
The I-CaM coach (I-CaM research nurse) conducts site visits every three
months with as needed support to provide tailored assistance and feed-
back to each site
Operation Between 4 and 8 h
depending on sites’
needs
Coaching The I-CaM coach provides support and technical assistance upon re-
quest from implementing sites
Sustainability Depending on sites’
needs
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intervention will monitor their activities (e.g., tracking
the number of eligible patients and the number who re-
ceived the CM intervention). At the end of the operation
phase, the research team will conduct semi–structured
interviews with case managers and champions. Both
champions and case managers will also complete a
questionnaire.
The sustainability phase
Following the implementation of the CM intervention, the
individual sites will continue the CM programs at their
discretion. The research team will monitor the activity at
each site and will be available for as-needed support to all
sites. Clinical outcomes (i.e., ED use, quality of life etc.)
will no more be measured. Finally, at the end of the sus-
tainability phase, case managers and champions will par-
ticipate in a final semi–structured interview with I-CaM
team and complete a last questionnaire.
Measures
Implementation-related measures
Table 2 summarizes the implementation measures by
phase. Implementation-related measures will target both
the implementation process evaluation (i.e., aiming to
describe the process of the implementation and its influ-
encing factors) and the implementation effectiveness
evaluation (i.e., the extent to which the implementation
was successful) and will include both quantitative and
qualitative approaches.
Quantitative measures assessing implementation
process We will use an adapted Stages of Implementa-
tion Completion tool SIC [31] to assess implementation
process by tracking the time of achievement of key im-
plementation milestones over the whole implementation
process. The SIC is a quasi-quantitative tool that mea-
sures progression of implementation activities (e.g.,
when engagement, provision of services and consultation
begin) organized in eight stages, by recording the dates
implementation activities were completed. The measure
yields three main scores, a) the number of stages com-
pleted, b) the time spent in each stage and, c) the pro-
portion of activities completed in each stage. Similarly,
we will adapt and use the SIC to evaluate implementa-
tion time-efforts and costs by assessing the costs at each
stages of the implementation process [32]. Specifically,
the SIC will be used to track both hours put forth
among staff involved in the implementation project on
sites (e.g., case managers) and hours put forth from
I-CaM; staff related to the implementation strategies.
The measure yields full time equivalent and averaged
salary costs scores. The SICs will be used over the whole
implementation project.
Influencing factors will be evaluated among champions
and case managers throughout the implementation process.
As previously mentioned, in the exploration phase we will
send an online survey to all ED services in the
French-speaking Switzerland to evaluate ED staff ’s interest
and awareness related the FUED problem and CM inter-
vention as well as their perceptions of needs regarding a
CM intervention within their service. Additional influen-
cing factors will be assessed at the end of the exploration,
preparation and operation phases with the Acceptability
Intervention Measure (AIM), the Intervention Appropriate-
ness Measure (IAM), the Feasibility of the Intervention
Measure (FIM) [33] and the Measure of Innovation Specific
Implementation Intentions (MISII) scale (see Tables 2 and
3) [34]. Remaining quantitative measures at the preparation
and operation phases include the Implementation Climate
Scale (ICS) [35] and the Organizational Readiness for Im-
plementation Change (ORIC) [36].
Quantitative measures assessing the implementation
effectiveness The adoption rate at the conclusion of
the exploration phase (i.e., the number of hospitals
included in the research project) will be yielded by
dividing the number of hospitals included in the re-
search project by the number of hospitals invited to
participate. At the operation and sustainability
phases, reach will be yielded by dividing the number
of patients receiving the CM intervention by the
total number of eligible patients. Effectiveness will
be examined using clinical outcomes assessed among
patients receiving the CM intervention (see mea-
sures below). At the operation and sustainability
phases, we will also examine the extent to which the
intervention is provided as intended (i.e., fidelity to
the CM intervention), using a checklist developed by
the I-Cam research team of the core components of
the CM intervention. This will be self-reported by
the case-managers. Finally, we will examine integra-
tion and normalization of the CM intervention using
the NoMad survey [37] and the measure of inner
context sustainment (MICS) (in development and
testing).
Qualitative measures Implementation process will be
further evaluated qualitatively during semi-structured in-
terviews with champions and case managers examining
influencing factors related the outer context (e.g., funding)
and the inner context (e.g., organizational readiness to
change, receptive context) [38, 39]. Finally, semi-structure
interviews will also further examine the CM intervention
normalization and integration [40], staff experience with
the CM intervention training and coaching, and staff ex-
perience regarding the CM intervention implementation
and delivery [41].
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Clinical measures
As described above, the CM intervention aims at reducing
ED visits and improving quality-of-life by targeting spe-
cific mechanisms, including empowerment, perceived
self-efficacy, health literacy and motivation to change. Ac-
cordingly, participants will be assessed at baseline and at
follow-ups on these clinical variables. Main outcomes will
include ED use and quality of life, whereas empowerment,
perceived self-efficacy, health literacy and motivation to
change will serve as secondary outcomes. Please see Table
3 presenting a summary of clinical measures.
Demographic variables Demographic variables (e.g.,
biological sex, age) will be assessed at baseline and will
serve to describe the sample. They will also serve as co-
variates in the main analyses.
Vulnerability determinants Vulnerability determinants
refer to dimensions that have been found to be positively
related to FUEDs [21]. Vulnerability determinants in-
clude social factors (e.g., lack of employment, limited so-
cial support), somatic factors (e.g., lower perceived
health-related quality of life), mental factors (e.g.,
Table 2 Summary of the Implementation Measures by Phase
Components Tool Participants Phase
Implementation process evaluation
Implementation process Stages of Implementation Completion (SIC) Champions, case managers, I-CaM
team
All
Implementation time-efforts and
costs
Stages of Implementation Completion (SIC) Champions, case managers, I-CaM
team
All
Influencing factors
ED staff awareness and interest in
FUED and CM
Online survey ED staff (public hospitals in the
French-speaking Switzerland)
Exploration
Semi-structured interview Champions Exploration
Acceptability, perceived
appropriateness and feasibility of the
CM
Acceptability Intervention Measure (AIM) and
Intervention Appropriateness Measure (IAM)
Feasibility of the Intervention measure (FIM)
Champions and case managers Preparation and
operation
Semi-structured interview Champions Exploration
Semi-structured interview Champions and case managers Operation
Intentions to use the CM Measure of Innovation Specific Implementation
Intentions
Champions and case managers Preparation,
operation
Implementation climate Implementation Climate scale (ICS)s Champions and case managers Preparation,
operation
Semi-structured interview Champions and case managers Preparation,
operation
Readiness for change Organizational Readiness for Implementation
Change (ORIC)
Champions and case managers Preparation,
operation
Implemention effectiveness
Adoption rate (hospitals included/
invited)
Monitoring of the activity on site Hospitals Exploration
Reach (patients receiving the CM/
eligible)
Monitoring of the activity on site Hospitals Operation,
sustainability
Implementation effectiveness
Clinical effectiveness Clinical outcomes (see Table 3) Patients receiving the intervention Operation
Fidelity of the CM Fidelity checklist Case managers Operation and
sustainability
Integration of the CM NoMad survey Champions and case managers Operation,
sustainability
Semi-structured interview Champions and case managers Operation and
sustainability
Normalization of the CM Measure of Inner Context Sustainment (MICS) Champions and case managers Operation and
sustainability
Semi-structured interview Champions and case managers Operation and
sustainability
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chronic mental disease), risk behaviors (e.g., alcohol and
other drug use) and health-care use (e.g., frequent ED
use). Vulnerability determinants will be assessed during
the case management; they will therefore be extracted
from medical records at baseline and will serve to de-
scribe the population and as covariates in the main
analyses.
ED visits Number of ED visits over the past year will be
extracted from medical records at baseline and at
12-months. Furthermore, ED visits over the past 6
months will be assessed at baseline, 6- and 12months.
ED visits at baseline will serve as covariate in the ana-
lyses, whereas the remaining measures will serve as out-
come in the mains analyses.
Health-care re-orientation Health-care re-orientation
will be extracted from the CM intervention medical re-
cords at 12months. Health-care reorientation at 12
months will be used as outcome.
Quality of life We will use the World Health Organiza-
tion’s WHOQOL-BREF [42] to evaluate quality of life at
baseline, 3-, 6- and 12-month follow-up.
Empowerment and self-efficacy We will evaluate em-
powerment and self-efficacy at baseline, 3-, 6- and 12
months, with the Health Care Empowerment Informed,
Committed, Collaborative and Engaged subscales of the
Health Care Empowerment Inventory [17] and Self-Efficacy
with the Self-Efficacy Scale [43].
Health literacy Similarly, we will assess health liter-
acy at baseline, 3-, 6- and 12 months using the Euro-
pean Health Literacy Project Questionnaire
(HLS-EU-16) [44].
Problematic alcohol use and precursors of alcohol
use changes We will measure problematic alcohol use
with the AUDIT-C [45]. In addition, we will examine
precursors of alcohol use changes (among participants
scoring ≥4 for males and ≥ 3 for females at the
AUDIT-C) with four single-item visual analog rulers
assessing importance, intentions, readiness and confi-
dence regarding alcohol use changes developed by Wal-
ton and colleagues [46]. These measures will be assessed
at baseline, 3-, 6-, and 12-months.
Data analysis plan
Implementation measures analysis
Descriptive statistics will be used to describe partici-
pants’ characteristics and to report implementation out-
comes. We will also test implementation measures
changes over time. Given that we will have a small sam-
ple size regarding implementation outcomes, these ana-
lyses will be triangulated with the qualitative data.
Specifically, interview contents will be transcribed and
explored to identify participants’ recurring codes and
categories; we will use conventional content analysis
(i.e., a systematic process of coding and classification)
[47] using a qualitative software (i.e., Atlas.ti or NVivo)
to examine qualitative data.
Clinical outcomes
Data will be screened for missing cases, outliers, and
normality of distributions using descriptive statistics and
plots. We will take appropriate steps to deal with miss-
ing data. First, we will conduct analyses to detect miss-
ingness patterns and test whether they may be
considered “ignorable.” [48] If more than 5% of outcome
data are missing, [49] we will divide the sample into 2
groups (i.e., missing, not missing), and use fully observed
variables to predict missingness on the affected outcome.
Table 3 Summary of the Clinical Measures in the Operation Phase
Components Tool Timing
Descriptive variables and covariates
Demographics Self-reported questionnaire Baseline
Vulnerability determinants Extracted from medical records Baseline
Clinical outcomes
ED visits Extracted from medical records Baseline, 6, and 12 months
Health-care reorientation Extracted from medical records Baseline, 3, 6, and 12 months
Quality of life WHOQOL-BREF Baseline, 3, 6, and 12 months
Empowerment Health Care Empowerment Inventory Baseline, 3, 6, and 12 months
Self-efficacy Self-Efficacy Scale Baseline, 3, 6 and 12months
Health literacy European Health Literacy Project Questionnaire Baseline, 3, 6 and 12months
Problematic alcohol use AUDIT-C Baseline, 3, 6 and 12months
Precursors of alcohol use Visual analog rulers assessing importance, intentions,
readiness and confidence regarding alcohol use changes
Baseline, 3, 6 and 12months
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If fully observed variables are not significant predictors,
missingness may be considered as “observed at random”
and fulfilling some criteria for “missing completely at
random” (MCAR) assumptions. In that case, we will use
multiple imputations procedures for measured outcomes
and direct maximum likelihood estimation for structural
models. If data missingness is non ignorable (MNAR),
we will use pattern-mixture models with multiple imput-
ation to model the missingness mechanism.
Main analyses will comprise multilevel models (i.e.,
MLM; mixed effects model) [50] utilizing appropriate
distributions for the outcome variables (e.g., Poisson,
negative binomial, normal). MLM examine the effect of
time (after receiving the CM intervention) on clinical
outcomes (e.g., quality of life, self-efficacy). MLM is ap-
propriate to handle nonindependence data. Specifically,
data will be clustered by participants (i.e., repeated mea-
sures) and by hospitals. MLM does not assume inde-
pendence of observations. Dependence is modeled
through random effects (representing different sources
of variability in the data). We will include sources of
random variability at the group level accounting for
between-group differences and another random effects
for the individual accounting for within-person differ-
ences in the repeated measures. MLM will be adjusted
for demographic variables (i.e., age and gender), ED use,
at-risk behaviors (e.g., alcohol use disorders) and health
status. Descriptive statistics will be conducted on SPSS
and MLM on STATA. The significance level will be set
at p = .05.
Discussion
This paper describes the protocol of a research project
aiming to implement a CM intervention tailored to
FUEDs in hospitals in the French-speaking region of
Switzerland, using a hybrid design that allows evaluating
both implementation and clinical outcomes [27].
Significance
This project addresses a critical area of ED health ser-
vices overuse using a practical solution, while taking an
innovative research approach that will contribute to the
growing literature on this topic. In terms of research
feasibility and innovation, implementation science is an
emerging field and serves as an ideal theoretical founda-
tion to complement the study of the key clinical out-
comes in diverse settings. The hybrid study design, and
rooting our project in the established GIF and Re-AIM
frameworks, provides a novel and feasible research ap-
proach. Findings of the current research project will pro-
vide useful information related to the mechanisms and
processes for implementing a CM intervention for
FUEDs into broader practice in the real-world settings.
This research project is also likely to have social and
economic implications. ED overuse and overcrowding is
a critical problem, and this project promotes a potential
solution. At the Lausanne University Hospital ED,
FUEDs accounted for 4.4% of ED patients yet 12.1% of
all ED visits (i.e., in 2008–2009; n = 5813) [4]. There is a
strong link between chronic disease and frequent ED
use, driven largely by the medical and social complexity
of these patients. Addressing ED overuse through CM
redirects FUEDs to more appropriate forms of care, in-
cluding primary care or substance abuse treatment,
while remaining cost-effective. By developing a CM
intervention program and studying its implementation
at multiple sites throughout the French-speaking region
of Switzerland, this project will provide insights and les-
sons for the broader use of CM interventions for health
care services overuse throughout Switzerland.
Finally, the CM intervention targets a defined popula-
tion— FUEDs —that is frequently highly vulnerable in
terms of medical complexity, suffering from multiple
chronic medical conditions, mental health and substance
abuse treatment needs, as well as modifiable social de-
terminants of health, including homelessness or low
household income. Therefore, this project also addresses
a medically and socially complex patient population with
chronic health care and social service needs, as well as
emphasizing improved communication and care coord-
ination within interdisciplinary care teams.
Limitations
There are several expected limitations in this current re-
search project that were carefully considered while de-
signing the study. Regarding clinical outcomes, the
design of this study allows patients’ evolution to be eval-
uated after receiving the CM intervention (i.e., pre-post
intervention; within-subjects design) in the sites imple-
menting the intervention. A well-known limitation re-
lated to this design is regression to the mean. In fact, we
previously conducted research using gold-standard ran-
domized controlled trial to test the CM intervention effi-
cacy [3] and the proposed within-subjects’ design is
consistent with Stages I and II treatment development
[51]. That said, interpretation of pre-post intervention
changes on health outcomes will be made with caution.
Next, self-reported data can be subject to reporting bias
[52, 53]. It can however, be reliable when measures are
developed for and piloted on the target population, time-
frames are manageable, confidentiality is ensured and
the target behavior is not stigmatized [54, 55]. The above
conditions were carefully considered when designing the
study, thereby minimizing the risk of self-report bias.
Furthermore, recruitment and retention can be a chal-
lenge with the target population (i.e., FUEDs), resulting
in missing data. However, previous work with a similar
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population, has demonstrated the possibility to attain ac-
ceptable 1-year retention rates [3]. Procedures for maxi-
mizing study retention will therefore be inspired from
the latter study. For instance, we will use incentives to
help retention over time (gift cards of increased value
for each follow-up assessment completed: 10, 20 and 20
CHF for 3, 6 and 12-month follow-up assessment). Add-
itionally, specific steps will be taken to address any bias
that may occur because of missing data as described pre-
viously. Finally, although not known at this stage, the pa-
tient sample size will be larger than the hospital sample
size; therefore, the implementation outcomes analyses
will not have the same level of analysis and will mostly
remain descriptive. To address this limitation, we will
use mixed methods (i.e., qualitative and quantitative
methods) to assess the implementation process and
outcomes.
Conclusion
FUEDs represent a vulnerable population multiply af-
fected by medical, psychological, social and substance-use
problems accounting for a disproportionally high number
of ED consultations. CM intervention tailored to this
population has been found to be generally effective in re-
ducing ED overcrowding and improving FUEDs’ quality of
life [3, 12–15]. There is, however, very limited knowledge
about how to translate and implement such an interven-
tion on a large scale to diverse clinical setting, including
community hospitals and non-academic centers. In re-
sponse, this research project aims to implement the CM
intervention in several hospitals in French-speaking
Switzerland while evaluating both implementation and
clinical outcomes, thereby providing key insights into the
mechanisms and processes for disseminating and imple-
menting this intervention into broader practice.
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